argenX SE Files April 2025 6-K Report
Ticker: ARGX · Form: 6-K · Filed: Apr 8, 2025 · CIK: 1697862
Sentiment: neutral
Topics: reporting, 6-K, foreign-private-issuer
TL;DR
ARGENX filed its April 6-K, standard reporting for foreign issuers.
AI Summary
On April 8, 2025, argenx SE filed a Form 6-K with the SEC. This report is for the month of April 2025 and is filed by a foreign private issuer. The company's principal executive offices are located in Amsterdam, the Netherlands.
Why It Matters
This filing indicates ongoing reporting compliance for argenx SE, a biotechnology company, which is crucial for investor confidence and regulatory adherence.
Risk Assessment
Risk Level: low — This filing is a routine report of foreign private issuer information and does not contain new material financial or operational disclosures.
Key Players & Entities
- ARGENX SE (company) — Registrant
- 001-38097 (company) — Commission File Number
- April 8, 2025 (date) — Filing Date
FAQ
What type of filing is this Form 6-K?
This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Who is the registrant filing this report?
The registrant is ARGENX SE.
What is the Commission File Number for ARGENX SE?
The Commission File Number for ARGENX SE is 001-38097.
Where are ARGENX SE's principal executive offices located?
ARGENX SE's principal executive offices are located at Laarderhoogtweg 25, 1101 EB Amsterdam, the Netherlands.
For what period is this Form 6-K report filed?
This Form 6-K report is filed for the month of April 2025.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 8, 2025 regarding ARGENX SE (ARGX).